共 50 条
- [22] Re: Shared Medical Appointments for Prostate Cancer Active Surveillance Followup Visits Editorial Comment [J]. JOURNAL OF UROLOGY, 2022, 207 (03): : 725 - 725
- [23] Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance EDITORIAL COMMENT [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : 959 - 960
- [24] Clinical and Demographic Characteristics Associated With Prostate Cancer Progression in Patients on Active Surveillance EDITORIAL COMMENT [J]. JOURNAL OF UROLOGY, 2012, 187 (05): : 1600 - 1600
- [25] Re: Quality of Life in Men Undergoing Active Surveillance for Localized Prostate Cancer Editorial Comment [J]. JOURNAL OF UROLOGY, 2013, 190 (02): : 536 - 537
- [26] Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience EDITORIAL COMMENT [J]. JOURNAL OF UROLOGY, 2016, 196 (06): : 1658 - 1658
- [27] Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era - Editorial comment [J]. JOURNAL OF UROLOGY, 2008, 180 (04): : 1340 - 1340
- [28] In response to Dr. Anfang's editorial supporting physician-assisted suicide (PAS),1 I offer these opposing comments [J]. JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2021, 49 (03): : 459 - 459
- [30] Re: Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts Editorial Comment [J]. JOURNAL OF UROLOGY, 2018, 199 (05): : 1112 - 1113